Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +47.88%
#2 Purr Purr +36.13%
#3 Pons Pons +35.51%
#4 TENDIES TENDIES +29.81%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +29.71%
#6 Starpower Starpower +27.24%
#7 StonkBroker StonkBroker +25.18%
#8 Magma Finance Magma Finance +24.68%
#9 SkyAI SkyAI +23.37%
#10 Kinetiq Kinetiq +22.82%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Provectus Biopharmaceuticals, Inc. Provectus Biopharmaceuticals, Inc.

Provectus Biopharmaceuticals, Inc.

PVCT
Rang in Aktien #28857
Provectus Biopharmaceuticals, Inc. is a clinical-stage biotechnology firm... Provectus Biopharmaceuticals, Inc. is a clinical-stage biotechnology firm dedicated to pioneering immunotherapy treatments. These therapies are grounded in its proprietary halogenated xanthene platform. Among its key developments is PV-10, an experimental autolytic cancer immunotherapy. This treatment is being explored for a range of adult solid tumor malignancies, encompassing melanoma and various gastrointestinal cancers (such as hepatocellular carcinoma, metastatic colorectal cancer to the liver, metastatic neuroendocrine tumors to the liver, and metastatic uveal melanoma to the liver). It also targets pediatric solid tumors, including neuroblastoma, Ewing sarcoma, rhabdomyosarcoma, and osteosarcoma. Additionally, Provectus is advancing oral formulations of pharmaceutical-grade rose bengal sodium (cGMP RBS) to combat a broad spectrum of conditions. These include adult solid tumors (such as head and neck, breast, testicular, and colorectal cancers), pediatric blood cancers like leukemia, acute respiratory syndromes such as coronavirus, infections caused by multi-drug resistant bacteria (specifically Gram-negative bacteria), and certain ocular conditions, notably infectious keratitis. Furthermore, the company is progressing PH-10, an investigational immuno-dermatology agent designed to address inflammatory skin conditions like psoriasis and atopic dermatitis. Originally established in 2002, the company was initially named Provectus Pharmaceuticals, Inc., before rebranding as Provectus Biopharmaceuticals, Inc. in December 2013. Its operations are headquartered in Knoxville, Tennessee.
Aktienkurs
$0.0573
Marktkapitalisierung
$24.08M
Veränderung (1 Tag)
0.53%
Veränderung (1 Jahr)
-28.55%
Land
US
Handel Provectus Biopharmaceuticals, Inc. (PVCT)

Kategorie

Healthcare
Preis PVCT mit Marktkapitalisierung von B
Provectus Biopharmaceuticals, Inc. Provectus Biopharmaceuticals, Inc.
PVCT
$0.0573
Marktkapitalisierung von Provectus Biopharmaceuticals, Inc.(PVCT)
Marktkapitalisierung: $24.08M
Mit Stand August 2026 hat Provectus Biopharmaceuticals, Inc. eine Marktkapitalisierung von $24.08M. Das macht Provectus Biopharmaceuticals, Inc. laut unseren Daten zum 28857th wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Provectus Biopharmaceuticals, Inc. von 1997 bis 2026
PVCT im Vergleich zu den Top 5 der beliebtesten stocks
Preis für PVCT Vermögenswert B Marktkapitalisierung von B Ergebnisse
Provectus Biopharmaceuticals, Inc. Provectus Biopharmaceuticals, Inc.
$12,611.89 $24.08M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.301T +22,010,179.49%
Provectus Biopharmaceuticals, Inc. Provectus Biopharmaceuticals, Inc.
$10,999.10 $24.08M
Apple Inc. Apple Inc.
AAPL
$4.623T +19,195,528.83%
Provectus Biopharmaceuticals, Inc. Provectus Biopharmaceuticals, Inc.
$9,854.14 $24.08M
Alphabet Inc. Alphabet Inc.
GOOG
$4.141T +17,197,357.50%
Provectus Biopharmaceuticals, Inc. Provectus Biopharmaceuticals, Inc.
$8,557.46 $24.08M
Microsoft Corporation Microsoft Corporation
MSFT
$3.597T +14,934,384.28%
Provectus Biopharmaceuticals, Inc. Provectus Biopharmaceuticals, Inc.
$6,757.28 $24.08M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.840T +11,792,704.55%